Literature DB >> 1904895

Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children.

M Ruiz-Moreno, M J Ruá, V Carreño, J A Quiroga, M Manns, K H Meyer zum Büschenfelde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1904895     DOI： 10.1016/0168-8278(91)90953-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Cytochrome P450 enzymes as human autoantigens.

Authors:  M P Manns
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.

Authors:  J Cianciara; T Laskus
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

Review 4.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 5.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

6.  Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.

Authors:  S Eddy; R Wim; V E Peter; R Tanja; T Jan; V S Werner
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

7.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

8.  Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.

Authors:  M Lenzi; S Bellentani; G Saccoccio; P Muratori; F Masutti; L Muratori; F Cassani; F B Bianchi; C Tiribelli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.